ASP Isotopes, Inc. (ASPI) has seen its shares surge by over 91% since July, driven in part by a supply contract for a highly enriched isotope worth approximately $9 million. The deal represents ASPI's first supply contract with a US customer and opens the door to potential future opportunities. ASPI is an advanced materials company specializing in the production of isotopes, which are in high demand from multiple sectors. The company has received significant interest from US and non-US customers and is strengthening its infrastructure to scale operations and meet growing demand. ASPI plans to enter commercial production in late 2023 to early 2024 and expects to sign additional supply contracts for other isotopes from 2025-2028. The company's innovative isotope enrichment technology is cost-effective, scalable, environmentally friendly, and unique compared to competing facilities. ASPI is well-positioned to capitalize on the increasing demand for reliable isotope sources due to geopolitical events and the retirement of major reactors producing medical isotopes. The company's low share structure and imminent facility completion make it an attractive investment opportunity.
Tue, 22 Aug 2023 09:17:04 GMT | Digital Journal